CCEP's Q2 Results: Testing Whether Easter Timing Masked Deeper Volume Pressures
Coca-Cola Europacific Partners Plc (CCEP) reports earnings on June 23, 2026, with investors focused on whether the world's largest Coca-Cola bottler can sustain the momentum from its strong Q1 performance. The central question is whether CCEP can deliver on its reaffirmed full-year guidance of 3% to 4% revenue growth amid a dynamic European consumer environment. With analyst sentiment improving and the stock trading near recent highs, this report will test the company's ability to balance volume growth with pricing discipline across its diverse geographic footprint.
Part 1: Earnings Preview
Coca-Cola Europacific Partners Plc is the world's largest independent Coca-Cola bottler by revenue, serving approximately 600 million consumers across Western Europe, including major markets in Spain, Germany, Great Britain, France, and the Benelux region. The company distributes a portfolio of non-alcoholic ready-to-drink beverages and operates through key geographic segments including Iberia, Germany, Great Britain, France, and Northern Europe.
CCEP is scheduled to report earnings on June 23, 2026. The company most recently reported Q1 2026 EPS of $0.89, reflecting strong operational execution in the first quarter. For the full year 2026, analysts expect EPS of $5.00 (based on 4 estimates ranging from $4.44 to $5.27), representing +7.53% growth. This compares favorably to the company's recent track record and reflects confidence in CCEP's ability to navigate the European beverage market.
Three key themes define this earnings story:
1. Revenue Growth Momentum and Full-Year Guidance Delivery: CCEP delivered a strong start to 2026 with Q1 reported revenue growth of +6.7% (FX-neutral +9.4%), significantly ahead of its full-year guidance range of 3% to 4%. The company reaffirmed this guidance in its April trading update, signaling confidence despite the strong Q1 performance. Investors will scrutinize whether this momentum continued into Q2 and whether management maintains or adjusts its full-year outlook. The ability to sustain mid-single-digit revenue growth while managing input cost pressures and consumer demand dynamics across diverse European markets will be critical.
2. Geographic Performance and Market Share Dynamics: CCEP's diversified European footprint provides both opportunities and challenges. The company's performance varies significantly across its key markets—Iberia, Germany, Great Britain, France, and Northern Europe—each with distinct consumer trends, competitive dynamics, and economic conditions. Investors will focus on volume trends versus pricing contributions to revenue growth, particularly in markets facing economic headwinds. Market share gains in key categories and the performance of the broader portfolio beyond core Coca-Cola brands will be important indicators of competitive positioning.
3. Margin Expansion and Capital Allocation: With operating margin improving from 11.76% in 2023 to 13.39% in 2025, CCEP has demonstrated strong operational leverage. The company's ability to continue expanding margins while investing in growth initiatives will be closely watched. Additionally, CCEP declared a first-half interim dividend of €0.82 per share (payable May 27, 2026) and reaffirmed its FY26 guidance for an annualized total dividend payout ratio of approximately 50%, signaling confidence in cash generation and shareholder returns.
Analyst commentary ahead of the release has been constructive. UBS recently adjusted its price target to $109 from $107 while maintaining a Buy rating, reflecting confidence in the company's execution. The consensus among 15 analysts shows 10 Strong Buys, 4 Holds, and 1 Strong Sell, with a mean price target of $107.67, implying approximately 11% upside from current levels. Analysts appear focused on CCEP's ability to balance volume growth with pricing discipline and continue delivering on its margin expansion story.
Part 3: What Analysts Are Saying
Analyst sentiment on CCEP is decidedly bullish heading into the earnings release. The current consensus rating stands at 4.20 out of 5.0, reflecting strong conviction in the stock's prospects. The analyst community shows 10 Strong Buys, 0 Moderate Buys, 4 Holds, 0 Moderate Sells, and 1 Strong Sell among 15 total recommendations, indicating broad-based support for the shares.
Sentiment has improved over the past month, with the average recommendation strengthening from 4.14 to 4.20. This positive shift coincides with CCEP's strong Q1 trading update and reaffirmed full-year guidance, which appear to have bolstered analyst confidence in the company's execution capabilities and growth trajectory.
The consensus price target of $107.67 implies approximately 11% upside from the current price of $96.98. The range of price targets is relatively wide, spanning from a low of $81.00 to a high of $118.00, reflecting differing views on valuation and growth potential. However, the clustering of Strong Buy ratings and the recent price target increase from UBS (to $109 from $107) suggest that leading analysts see meaningful appreciation potential as CCEP continues to execute on its strategic initiatives and deliver consistent financial performance across its European markets.
Part 4: Technical Picture
The Barchart Technical Opinion for CCEP currently shows a Buy signal at 72%, representing a significant strengthening from 56% Buy one week ago and a dramatic reversal from 24% Sell one month ago. This rapid improvement in technical sentiment reflects strong recent momentum as the stock has rallied heading into the earnings release.
Timeframe Analysis:
- Short-term (50% Buy): Moderate buy signal indicates positive near-term momentum, though not at extreme levels
- Medium-term (50% Buy): Consistent buy signal in the intermediate timeframe suggests sustained upward pressure
- Long-term (100% Buy): Strong buy signal reflects robust longer-term trend strength and positive structural positioning
The trend is characterized as Weak in strength but Weakening in direction, suggesting that while the overall technical picture remains constructive, momentum may be moderating after the recent rally. This creates a somewhat mixed technical backdrop heading into earnings, with strong longer-term support but potential near-term vulnerability.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $97.94 | 50-Day MA | $94.87 |
| 10-Day MA | $97.63 | 100-Day MA | $96.62 |
| 20-Day MA | $95.07 | 200-Day MA | $93.26 |
CCEP is trading at $96.98, positioned above its 20-day ($95.07), 50-day ($94.87), 100-day ($96.62), and 200-day ($93.26) moving averages, but below its 5-day ($97.94) and 10-day ($97.63) moving averages. This configuration suggests the stock has pulled back slightly from very recent highs but remains in a solid uptrend across longer timeframes. The stock's position above all major long-term moving averages provides technical support, while the minor pullback from short-term averages may offer a more favorable entry point for those anticipating a positive earnings reaction. The overall technical setup is moderately supportive heading into the release, with the strong longer-term trend providing a cushion, though the weakening momentum suggests investors should be prepared for potential volatility around the earnings announcement.